UnitedHealth stock forecast
UnitedHealth's weighted scenario is $357.26 in October 2027, $394.17 in October 2028, and $441.90 in October 2029. It hinges on an earnings recovery that restores confidence.
Where could UnitedHealth's shares be by 2029?
The weighted price is $357.26 in October 2027, a 3% loss including dividends. It reaches $394.17 in October 2028, a 10% gain. By October 2029, it reaches $441.90, a 25% gain.
The bear endpoint is $256.44. The bull endpoint is $664.40. Today’s price is $377.76. The bear case carries a 30% probability, the base case 50%, and the bull case 20%.
| Case | Probability | October 2027 | October 2028 | October 2029 |
|---|---|---|---|---|
| Bear | 30 % | 262.97 (-28 %) | 260.67 (-26 %) | 256.44 (-25 %) |
| Base | 50 % | 380.99 (+3 %) | 417.37 (+16 %) | 464.17 (+31 %) |
| Bull | 20 % | 439.34 (+19 %) | 536.41 (+47 %) | 664.40 (+84 %) |
| Weighted | 100 % | 357.26 (-3 %) | 394.17 (+10 %) | 441.90 (+25 %) |
What has to go right or wrong for UnitedHealth?
The weighted forecast implies a 3% loss including dividends in October 2027 and a 25% gain including dividends in October 2029. Bear, base and bull cases carry 30%, 50% and 20% probabilities. The recovery must align medical costs with pricing, move Optum Health toward its 6%–8% margin target, and let cash generation support investment and payouts. By December 31, 2026, prior authorization—insurer approval required before certain care or medicines—is committed to fall 30%. December’s 2027 outlook tests the recovery. Medicare compliance and tax disputes remain unresolved. The investment turns on whether scale becomes durable per-share earnings.
The bull case requires durable cost control, sound payments and documentation, stronger Optum Health risk-contract margins and cash generation sufficient to expand buybacks. It gives $439.34 in October 2027 and $664.40 in October 2029. Its 20% probability reflects the upside from execution, but also the absence of proof through a full pricing cycle.
How much cash does UnitedHealth really make?
Operating cash flow was $19.7 billion in 2025, but UnitedHealth sold $3.0 billion of receivables and received the cash early. Excluding that acceleration gives a lower sensitivity measure. Capital also sits inside regulated insurance subsidiaries, where it must support claims and may not be freely transferred to the parent. Equity rose while operating return on equity weakened, so the capital table shows quantity without proving quality.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| EPS, diluted | 13.23 | 15.51 | 23.86 | 21.18 | 18.08 |
| − Dividends, per share | 8.69 | 8.11 | 7.21 | 6.31 | 5.52 |
| − Share buybacks, per share | 6.09 | 9.69 | 8.53 | 7.37 | 5.23 |
| = Kept, per share | 8.12 | 7.50 | 7.33 | ||
| = Paid out more, per share | 1.54 | 2.29 |
What this means. In 2025 and 2024, the company paid shareholders more than it earned because dividends plus share buybacks exceeded its profit per share.
What does an investor pay for UnitedHealth today?
| Today (Oct 14, 2026) | |
|---|---|
| Share price | 377.76 |
| Market value (calculated) | 339,075 |
| P/E, last 12 months (calculated) | 21.6x |
| P/E on core earnings, last 12 months (calculated) | 18.5x |
| P/E, next 12 months (calculated) | 16.7x |
| Dividend yield (calculated) | 2.5% |
What this means. The share price is the closing price from October 13, even though the table is dated October 14.